Related Experiment Video
Updated: Jul 13, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
Nuclear thioredoxin-1 is required to suppress cisplatin-mediated apoptosis of MCF-7 cells
Xiao-Ping Chen1, Shou Liu, Wen-Xin Tang
1Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Technology, Wuhan, 430074, China.
Abstract:
Different cell line with increased thioredoxin-1 (Trx-1) showed a decreased or increased sensitivity to cell killing by cisplatin. Recently, several studies found that the subcellular localization of Trx-1 is closely associated with its functions. In this study, we explored the association of the nuclear Trx-1 with the cisplatin-mediated apoptosis of breast cancer cells MCF-7. Firstly, we found that higher total Trx-1 accompanied by no change of nuclear Trx-1 can not influence apoptosis induced by cisplatin in MCF-7 cells transferred with Trx-1 cDNA. Secondly, higher nuclear Trx-1 accompanied by no change of total Trx-1 can protect cells from apoptosis induced by cisplatin. Thirdly, high nuclear Trx-1 involves in the cisplatin-resistance in cisplatin-resistive cells. Meanwhile, we found that the mRNA level of p53 is closely correlated with the level of nuclear Trx-1. In summary, we concluded that the nuclear Trx-1 is required to resist apoptosis of MCF-7 cells induced by cisplatin, probably through up-regulating the anti-apoptotic gene, p53.
Insights
Nuclear thioredoxin-1 (Trx-1) protects breast cancer cells from cisplatin-induced apoptosis. Increased nuclear Trx-1 is linked to cisplatin resistance, likely by upregulating the p53 gene.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Thioredoxin-1 (Trx-1) levels influence sensitivity to cisplatin.
- Subcellular localization of Trx-1 is critical for its function.
- The role of nuclear Trx-1 in breast cancer cell response to cisplatin is not fully understood.
Purpose of the Study:
- To investigate the association between nuclear Trx-1 and cisplatin-mediated apoptosis in MCF-7 breast cancer cells.
- To determine if nuclear Trx-1 contributes to cisplatin resistance.
Main Methods:
- MCF-7 cells were transfected with Trx-1 cDNA.
- Total and nuclear Trx-1 levels were assessed.
- Cisplatin-induced apoptosis was measured.
- mRNA levels of p53 were analyzed.
Main Results:
- Increased total Trx-1 without altered nuclear Trx-1 did not affect cisplatin-induced apoptosis.
- Elevated nuclear Trx-1, independent of total Trx-1, protected cells from cisplatin-induced apoptosis.
- High nuclear Trx-1 correlated with cisplatin resistance in resistant cell lines.
- Nuclear Trx-1 levels were closely correlated with p53 mRNA levels.
Conclusions:
- Nuclear Trx-1 plays a crucial role in resisting cisplatin-induced apoptosis in MCF-7 cells.
- Nuclear Trx-1 likely confers cisplatin resistance by upregulating the anti-apoptotic gene p53.
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Negative Regulator Molecules
